cbdMD, Inc. (YCBD)
NYSEAMERICAN: YCBD · Real-Time Price · USD
0.910
-0.060 (-6.19%)
At close: Apr 28, 2026, 4:00 PM EDT
0.855
-0.056 (-6.10%)
Pre-market: Apr 29, 2026, 5:05 AM EDT
cbdMD Revenue
cbdMD had revenue of $5.02M in the quarter ending December 31, 2025, a decrease of -1.89%. This brings the company's revenue in the last twelve months to $19.09M, down -0.66% year-over-year. In the fiscal year ending September 30, 2025, cbdMD had annual revenue of $19.19M, down -1.50%.
Revenue (ttm)
$19.09M
Revenue Growth
-0.66%
P/S Ratio
0.50
Revenue / Employee
$454,617
Employees
42
Market Cap
9.55M
Revenue Chart
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Full DefinitionRelated Stocks
| Company Name | Revenue |
|---|---|
| Biofrontera | 41.71M |
| Sunshine Biopharma | 36.31M |
| Sonoma Pharmaceuticals | 17.72M |
| China Pharma Holdings | 4.14M |
| China SXT Pharmaceuticals | 1.54M |
| Akanda | 836.66K |
| RedHill Biopharma | 286.00K |
| Gelteq | 270.85K |
YCBD News
- 27 days ago - cbdMD Launches Clinical Healthcare Channel to Support First Federal Pathway for Hemp-Derived CBD in Medicare - PRNewsWire
- 4 weeks ago - cbdMD Transcript: AGM 2026 - Transcripts
- 2 months ago - cbdMD Earnings Call Transcript: Q1 2026 - Transcripts
- 2 months ago - cbdMD Reports Sequential Revenue Growth, Improved Liquidity, and Strong Start to Fiscal 2026 - PRNewsWire
- 2 months ago - cbdMD, Inc. to Host Conference Call to Discuss December 31, 2025 First Quarter Results - PRNewsWire
- 3 months ago - cbdMD's Herbal Oasis Expands into Louisiana with Morales Beverage Group Following Strong Texas Momentum - PRNewsWire
- 3 months ago - cbdMD Strengthens Regulatory Science Platform to Support Emerging Regulatory Cannabinoid Evaluation Pathways - PRNewsWire
- 3 months ago - cbdMD Announces Strategic Acquisition of Bluebird Botanicals - PRNewsWire